Covestor LTD Codexis, Inc. Transaction History

Covestor LTD

$155 Million
Q2 2024

A detailed history of Covestor LTD transactions in Codexis, Inc. stock. As of the latest transaction made, Covestor LTD holds 24 shares of CDXS stock, worth $75. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 25 4.0%

Holding current value

$75

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$2.65 - $3.92 $2 - $3	-1 Reduced 4.0%	24 $0
Q1 2024 May 10, 2024	SELL	$2.59 - $4.65 $2 - $4	-1 Reduced 3.85%	25 $0
Q4 2023 Feb 09, 2024	SELL	$1.54 - $3.37 $4 - $10	-3 Reduced 10.34%	26 $0
Q3 2023 Nov 13, 2023	BUY	$1.5 - $3.75 $24 - $60	16 Added 123.08%	29 $0
Q2 2023 Aug 11, 2023	SELL	$2.21 - $4.43 $2 - $4	-1 Reduced 7.14%	13 $0
Q4 2022 Feb 13, 2023	SELL	$4.26 - $6.84 $4 - $6	-1 Reduced 6.67%	14 $0
Q3 2022 Nov 14, 2022	BUY	$6.06 - $12.86 $18 - $38	3 Added 25.0%	15 $0
Q2 2022 Aug 10, 2022	SELL	$8.35 - $21.89 $25 - $65	-3 Reduced 20.0%	12 $0
Q1 2022 May 13, 2022	SELL	$16.97 - $31.93 $67 - $127	-4 Reduced 21.05%	15 $0
Q4 2021 Feb 10, 2022	BUY	$25.61 - $41.78 $486 - $793	19 New	19 $1,000

Others Institutions Holding CDXS

# of Institutions

126

Shares Held

48.2M

Call Options Held

33.7K

Put Options Held

20.2K

Black Rock Inc. New York, NY

6.79M
Shares

$21.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.09M
Shares

$12.9 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

3.63M
Shares

$11.5 Million
0.75% of portfolio
Opaleye Management Inc. Boston, MA

3.46M
Shares

$10.9 Million
2.74% of portfolio
Baillie Gifford & CO

2.71M
Shares

$8.56 Million
0.01% of portfolio

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $207M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.

Account